Darch Sophie E, Kragh Kasper N, Abbott Evelyn A, Bjarnsholt Thomas, Bull James J, Whiteley Marvin
Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
Institute of Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, USA.
mBio. 2017 Apr 4;8(2):e00240-17. doi: 10.1128/mBio.00240-17.
The microbial communities inhabiting chronic infections are often composed of spatially organized micrometer-sized, highly dense aggregates. It has recently been hypothesized that aggregates are responsible for the high tolerance of chronic infections to host immune functions and antimicrobial therapies. Little is currently known regarding the mechanisms controlling aggregate formation and antimicrobial tolerance primarily because of the lack of robust, biologically relevant experimental systems that promote natural aggregate formation. Here, we developed an model based on chronic infection of the cystic fibrosis (CF) lung. This model utilizes a synthetic sputum medium that readily promotes the formation of aggregates with sizes similar to those observed in human CF lung tissue. Using high-resolution imaging, we exploited this model to elucidate the life history of and the mechanisms that this bacterium utilizes to tolerate antimicrobials, specifically, bacteriophage. In the early stages of growth in synthetic sputum, planktonic cells form aggregates that increase in size over time by expansion. In later growth, migrant cells disperse from aggregates and colonize new areas, seeding new aggregates. When added simultaneously with phage, was readily killed and aggregates were unable to form. When added after initial aggregate formation, phage were unable to eliminate all of the aggregates because of exopolysaccharide production; however, seeding of new aggregates by dispersed migrants was inhibited. We propose a model in which aggregates provide a mechanism that allows to tolerate phage therapy during chronic infection without the need for genetic mutation. Bacteria in chronic infections often reside in communities composed of micrometer-sized, highly dense aggregates. A primary challenge for studying aggregates has been the lack of laboratory systems that promote natural aggregate formation in relevant environments. Here, we developed a growth medium that mimics chronic lung infection and promotes natural aggregate formation by the bacterium High-resolution, single-cell microscopy allowed us to characterize 's life history-seeding, aggregate formation, and dispersal-in this medium. Our results reveal that this bacterium readily forms aggregates that release migrants to colonize new areas. We also show that aggregates allow to tolerate therapeutic bacteriophage addition, although this treatment limits dissemination by targeting migrants.
栖息于慢性感染中的微生物群落通常由空间组织化的微米级高密度聚集体组成。最近有人提出假说,聚集体是慢性感染对宿主免疫功能和抗菌疗法具有高耐受性的原因。目前对于控制聚集体形成和抗菌耐受性的机制知之甚少,主要是因为缺乏能促进自然聚集体形成的强大、生物学相关的实验系统。在此,我们基于囊性纤维化(CF)肺部的慢性感染开发了一个模型。该模型利用一种合成痰液培养基,它能轻易促进形成大小与在人类CF肺组织中观察到的相似的聚集体。利用高分辨率成像,我们利用这个模型来阐明该菌的生活史以及该细菌用于耐受抗菌剂,特别是噬菌体的机制。在合成痰液中生长的早期阶段,浮游细胞形成聚集体,随着时间推移通过扩张而增大尺寸。在后期生长中,迁移细胞从聚集体中分散并定殖到新区域,形成新的聚集体。当与噬菌体同时添加时,该菌很容易被杀死且聚集体无法形成。当在初始聚集体形成后添加时,由于胞外多糖的产生,噬菌体无法消除所有聚集体;然而,分散的迁移细胞形成新聚集体的过程受到抑制。我们提出一个模型,其中聚集体提供了一种机制,使该菌在慢性感染期间无需基因突变就能耐受噬菌体疗法。慢性感染中的细菌通常存在于由微米级高密度聚集体组成的群落中。研究聚集体的一个主要挑战是缺乏能在相关环境中促进自然聚集体形成的实验室系统。在此,我们开发了一种模拟慢性肺部感染并促进该菌自然聚集体形成的生长培养基。高分辨率的单细胞显微镜使我们能够在这种培养基中表征该菌的生活史——接种、聚集体形成和分散。我们的结果表明,这种细菌很容易形成聚集体,释放迁移细胞以定殖到新区域。我们还表明,聚集体使该菌能够耐受治疗性噬菌体的添加,尽管这种处理通过靶向迁移细胞限制了该菌的传播。